Enterobacteriaceae Infections Clinical Trial
Official title:
Neonatal Acquisition of ESBL-PE in a Low-income Country
Enterobacteriaceae, more specifically Escherichia coli and Klebsiella pneumoniae, are the bacteria most often responsible for neonatal infections in low-income countries. Infections caused by multidrug-resistant Enterobacteriaceae: Extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E), are more often associated with an unfavorable outcome of the infection. Enterobacteriaceae colonize the digestive tract which is the first step in developing a potential infection. Very few studies have been carried out at the community level. Colonization of the mother with ESBL-E is generally considered to be a major route of acquisition. The carrying of ESBL-E by other family members and other potential sources of transmission (food, objects and surfaces in contact with the newborn) have never been documented. In addition, with a view to offering an intervention adapted to the local context, the local cultural determinants which govern the interactions of the newborn with his environment are important to understand.
This is a single-center prospective cohort of all members living in the same household in which a newborn baby has just been born. The study consists to: - recruit a cohort of all members of 60 households in which a newborn has just been born - carry out semi-structured interviews and direct participant observation. This study is divided in two parts : - the epidemiological part : the documentation of colonization by E-ESBL by sampling the stools of the newborn, of all members of the household, and sampling of food given to the child, from surfaces in contact with it. - the anthropological part : Semi-structured interviews with key people in the structuring of the social and family environment of the newborn and participant direct observation of households. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02400268 -
Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae
|
Phase 3 | |
Completed |
NCT03401242 -
Prevalence of ESBL and CPE in French Nursing Homes
|
||
Not yet recruiting |
NCT03967301 -
Prevention and Decolonization of Multidrug-resistant Bacteria With Probiotics
|
N/A | |
Completed |
NCT02795949 -
Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae
|
Phase 3 | |
Completed |
NCT00573235 -
Epidemiology of Community - Associated Extended-spectrum Beta-lactamases (ESBL) Producing Escherichia Coli
|
||
Recruiting |
NCT00404625 -
Infections Caused by ESbL-Producing Enterobacteriaceae in Italy
|
N/A | |
Completed |
NCT00573521 -
Risk Factors for Piperacillin/Tazobactam Resistance in Extended-Spectrum Beta-Lactamase (ESBL) Producing Organisms
|
||
Recruiting |
NCT03671967 -
PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)
|
Phase 4 | |
Enrolling by invitation |
NCT03924934 -
Community-associated Highly-Resistant Enterobacterales
|
||
Completed |
NCT03477084 -
Understanding and Modeling Reservoirs, Vehicles and Transmission of ESBL-producing Enterobacteriaceae in the Community and Long Term Care Facilities
|
||
Not yet recruiting |
NCT05632315 -
PMT for MDRO Decolonization
|
Phase 2 | |
Withdrawn |
NCT03527056 -
Pilot Study Using Oral Capsule FMT to Decolonize GI CRE
|
Early Phase 1 | |
Completed |
NCT00826670 -
Enterobacteriaceae Producing Extended-spectrum β-lactamases (ESBL) Decolonization Study
|
Phase 4 | |
Not yet recruiting |
NCT04903886 -
Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae
|
||
Completed |
NCT02482051 -
Ultra Rapid Culture Independent Detection of High-Priority Carbapenem Resistant Enterobacteriaceae Directly From Blood
|
||
Recruiting |
NCT00894036 -
The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss Children
|
N/A | |
Suspended |
NCT05355350 -
PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections
|
Phase 4 | |
Recruiting |
NCT05516433 -
Effect of Imipenem and Meropenem on the Digestive Microbiota and the Emergence and Carriage of Multidrug-resistant Bacteria
|
||
Recruiting |
NCT02450942 -
18F-FDS PET/CT in Healthy Volunteers and Patients With Suspected Infection
|
Early Phase 1 | |
Recruiting |
NCT05035342 -
Fecal Transplantation to Eradicate Colonizing Emergent Superbugs
|
Phase 3 |